205174 Substance Abuse and Mental Health Services Administration (SAMHSA)'s Center for Substance Abuse Treatment (CSAT) Screening, Brief Intervention and Referral to Treatment (SBIRT) cross-site evaluation preliminary findings: Outcomes from the initiative

Monday, November 9, 2009: 1:42 PM

Arnie Aldridge, MA , RTI International, Raligh, NC
Jeremy Bray, PhD , RTI International, Raligh, NC
SAMHSA/CSAT funded a program initiative to help expand States' continuum of care to include SBIRT in general medical and other community settings (e.g., community health centers, hospitals, and emergency departments). In FY2005, six States and a Tribal Organization received SAMHSA co-operative grant funding to implement the SBIRT program in selected sites. As part of this effort, a cross-site evaluation of the SBIRT initiative is being conducted to study its impact on the existing treatment system, as well as on the outcomes of patients who receive SBIRT services. This presentation will focus on findings regarding changes in patients' substance use behaviors associated with SBIRT, factors influencing outcomes, and secondary outcomes. The presentation will explore the moderating and mediating individual, SBIRT model and environmental factors that influence SBIRT's impact. Estimates will be for all patients pooled across the grantees and also broken out by the type of health care setting in which they were screened.

Learning Objectives:
Through this presentation, the participant (learner) in this session will be able to: 1. Discuss findings on the association of changes in patients’ substance use behaviors with receipt of SBIRT using pre-post multivariate models and quasi-experimental models. 2. Discuss findings on the association of changes in patients’ substance use behaviors with SBIRT individual characteristics, model characteristics and other environmental factors. 3. Discuss the association between SBIRT influenced substance use behaviors and health care utilization, crime, employment status, wage, and productivity.

Keywords: Substance Abuse Treatment, Evaluation

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have read the APHA policy on full disclosure and I declare that: I wish to disclose that I have NO financial interests or other relationship with the manufacturers of commercial products, suppliers of commercial services or commercial supporters WITH THE EXCEPTION THAT JBS International, Inc., RTI, Inc., the University of Connecticut, and The Avisa Group and were funded by the Center for Susbstance Abuse Treatment, Substance Abuse and Mental Health Services Administration to be part of a cross-site evaluation team to conduct a cross-site evaluation of CSAT’s SBIRT grantees.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.